Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4507571000168119 | Memantine (LAPL) (memantine hydrochloride 5 mg) tablet, 14 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4507581000168116 | Memantine (LAPL) 5 mg tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Memantine (LAPL) 5 mg tablet, 14 | Is a | memantine hydrochloride 5 mg tablet, 14 | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 14 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 14 | has TP | Memantine (LAPL) | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 14 | has TPUU | Memantine (LAPL) 5 mg tablet | true | Inferred relationship | Some | 1647650071 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Memantine (LAPL) 5 mg tablet, 14, blister pack | Is a | True | Memantine (LAPL) 5 mg tablet, 14 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR